[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340718-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340718-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","integrating-immune-multi-omics-and-machine-learning-to-improve-prognosis-immune-landscape-and-sensitivity-to-first-and-second-line-treatments-for-head-and-neck-squamous-cell-carcinoma","Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma","","Immune checkpoint inhibitors have become standard for head and neck squamous cell carcinoma, yet predicting treatment effectiveness for patients with the same TNM stage remains difficult due to limited biomarkers. This study integrates multi-omics (mRNA, lncRNA, miRNA, DNA methylation, somatic mutations) with 10 clustering algorithms to define two molecular subtypes (CS1, CS2) and uses immune-regulated genes with machine learning to build a consensus immunotherapy signature (CMPIS). The CMPIS prognostic model is validated across multiple datasets and linked to differential sensitivity to immunotherapy, targeted therapy, radiotherapy, and chemotherapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/integrating-immune-multi-omics-and-machine-learning-to-improve-prognosis-immune-landscape-and-sensitivity-to-first-and-second-line-treatments-for-head-and-neck-squamous-cell-carcinoma/340718/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/integrating-immune-multi-omics-and-machine-learning-to-improve-prognosis-immune-landscape-and-sensitivity-to-first-and-second-line-treatments-for-head-and-neck-squamous-cell-carcinoma/340718.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is predicting immune checkpoint inhibitor effectiveness in HNSCC still challenging?","Question",{"text":63,"@type":64},"Patients with the same TNM stage can respond differently, and effective biomarkers are insufficient for accurate outcome prediction.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the two cancer subtypes (CS1 and CS2) identified?",{"text":68,"@type":64},"The study combined multi-omics data (mRNA, lncRNA, miRNA, DNA methylation, somatic mutations) with 10 clustering algorithms to obtain two distinct molecular subtypes.",{"name":70,"@type":61,"acceptedAnswer":71},"What does CMPIS indicate about treatment sensitivity?",{"text":72,"@type":64},"Patients with lower CMPIS showed higher sensitivity to immunotherapy and chemotherapy, whereas higher CMPIS patients were more responsive to radiotherapy and EGFR-targeted treatments.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340718,1790875173,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nIntegrating immune multi-omicsand machine learning to improve prognosis, immune landscape, and sensitivity to first-and secondline treatments for head and necksquamous cell carcinoma  \nJi Yin1,2,4, Lin Xu1,4, Shange Wang1, Linshuai Zhang1, Yujie Zhang1, Zhenwei Zhai1,2, Pengfei Zeng1,2, Marcin Grzegorzek3 & Tao Jiang1,2􀀍  \nIn recent years, immune checkpoint inhibitors (ICIs) has emerged as a fundamental component of the standard treatment regimen for patients with head and neck squamous cell carcinoma (HNSCC) . However, accurately predicting the treatment effectiveness of ICIs for patients at the same TNM stage remains a challenge. In this study, we first combined multi-omics data (mRNA, lncRNA, miRNA, DNA methylation, and somatic mutations) and 10 clustering algorithms, successfully identifying two distinct cancer subtypes (CSs) (CS1 and CS2). Subsequently, immune-regulated genes (IRGs) and machine learning algorithms were utilized to construct a consensus machine learning-driven prediction immunotherapy signature (CMPIS) . Further, the prognostic model was validated and compared across multiple datasets, including clinical characteristics, external datasets, and previously published models. Ultimately, the response of different CMPIS patients to immunotherapy, targeted therapy, radiotherapy and chemotherapy was also explored. First, Two distinct molecular subtypes were successfully identified by integrating immunomics data with machine learning techniques, and it was discovered that the CS1 subtype tended to be classified as “cold tumors” or “immunosuppressive tumors”, whereas the CS2 subtype was more likely to represent “hot tumors” or \"immune-activated tumors\". Second, 303 different algorithms were employed to construct prognostic models and the average C-index value for each model was calculated across various cohorts. Ultimately, the StepCox [forward] + Ridge algorithm, which had the highest average C-index value of 0.666, was selected and this algorithm was used to construct the CMPIS predictive model comprising 16 key genes. Third, this predictive model was compared with patients’ clinical features, such as age, gender, TNM stage, and grade stage. The findings indicated that this prognostic model exhibited the best performance in terms ofC-index andAUC values. Additionally, it was compared with previously published models and it was found that the C-index of CMPIS ranked in the top 5 among 94 models across theTCGA, GSE27020, GSE41613, GSE42743, GSE65858, and META datasets. Lastly, the study revealed that patients with lowerCMPIS were more sensitive to immunotherapy and chemotherapy, while those with higher CMPIS were more responsive to radiation therapy and EGFR-targeted treatments. In summary, our study identified two CSs (CS1 and CS2) of HNSCC using multi-omics data and predicted patient prognosis and treatment response by constructing the CMPIS model with IRGs and 303 machine learning algorithms, which underscores the importance of immunotherapy biomarkers in providing more targeted, precise, and personalized immunotherapy plans for HNSCC patients, significantly contributing to the optimization of clinical treatment outcomes.  \nKeywords Head and neck squamous cell carcinoma, Immune checkpoint inhibitors, Consensus machine learning-driven prediction immunotherapy signature, Multi-omics, Machine learning, Prognosis  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \n1School of Intelligent Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China. 2The Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine, Chengdu, China. 3Institute of Medical Informatics, University of Lübeck, Lübeck, Germany. 4These authors contributed equally: Ji Yin and Lin Xu.  \n􀀍 [email: jiangtop@cdutcm.edu.cn](email: jiangtop@cdutcm.edu.cn)  \nHead and neck squamous cell carcinoma (HNSCC) is","cbCaifeZlytS0n3p","https://ap.wps.com/l/cbCaifeZlytS0n3p","pdf",6944470,"English","# Background\n## Limits of biomarkers for TNM-matched patients\n# Methods\n## Multi-omics integration and clustering\n## Construction of CMPIS using immune-regulated genes and machine learning\n## Model validation and comparison\n# Results\n## Two molecular subtypes: CS1 and CS2\n## Selected StepCox (forward) + Ridge model and CMPIS genes\n## Prognostic performance and ranking vs prior models\n## Predicted treatment sensitivity across therapy types\n# Conclusion\n## Clinical implications for personalized immunotherapy planning","[{\"question\":\"Why is predicting immune checkpoint inhibitor effectiveness in HNSCC still challenging?\",\"answer\":\"Patients with the same TNM stage can respond differently, and effective biomarkers are insufficient for accurate outcome prediction.\"},{\"question\":\"How were the two cancer subtypes (CS1 and CS2) identified?\",\"answer\":\"The study combined multi-omics data (mRNA, lncRNA, miRNA, DNA methylation, somatic mutations) with 10 clustering algorithms to obtain two distinct molecular subtypes.\"},{\"question\":\"What does CMPIS indicate about treatment sensitivity?\",\"answer\":\"Patients with lower CMPIS showed higher sensitivity to immunotherapy and chemotherapy, whereas higher CMPIS patients were more responsive to radiotherapy and EGFR-targeted treatments.\"}]","Integrating immune multi-omics and machine learning to improve prognosis, immune landscape, and sensitivity to first- and second-line treatments for head and neck squamous cell carcinoma | PDF",1790038459,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c76e217527f9acaf5d24c106228a01bf.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d45d72a78d85b4f0b5b28cb7e13626d.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cccf0377019f9a386129b3ff13ddf3b4.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39611716b396482619ab3dcada1009df.webp",980,1287]